In contrast, loss of METTL5 promoted TAC-induced cardiac remodeling with progression to heart failure in the METTL5-cKO group, which was associated with significantly increased left ventricular internal dimension (LVID) and dramatic reduced fraction shortening (FS) (Figures 2B,C and Table 1). Here, METTL5 is linked to heart failure.